<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01224886</url>
  </required_header>
  <id_info>
    <org_study_id>AGIR</org_study_id>
    <secondary_id>Protocol 188/10</secondary_id>
    <nct_id>NCT01224886</nct_id>
  </id_info>
  <brief_title>Age and Insulin Resistance</brief_title>
  <acronym>AGIR</acronym>
  <official_title>In French AGIR Means to Get Into Action. This is the Generic Title of Our Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Lausanne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre Hospitalier Universitaire Vaudois</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Lausanne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Insulin resistance is a crucial factor for the development of type 2 diabetes and a major
      health problem for older adults. It is the principal mechanism by which obesity is considered
      to increase the risk for type 2 diabetes and is a key feature of the metabolic syndrome. The
      elevated prevalence of obesity and type 2 diabetes in the older population has important
      consequences on the morbidity and mortality as well as on the economic burden on society.
      Controversy currently exists as to whether or not aging contributes to insulin resistance.
      Many potential factors confound the association between aging and insulin resistance,
      including obesity and physical inactivity.

      Ectopic lipid depositions, defined as an excess accumulation of triglycerides in non adipose
      tissues such as in the liver (intrahepatic lipids) and within the muscle fibers
      (intramyocellular lipids), are positively associated with obesity and insulin resistance.
      Furthermore, the accumulation of intracellular lipids is often cited as being a key
      determinant in the underlying mechanisms of insulin resistance. In addition of playing an
      important role in obesity and type 2 diabetes, these ectopic fat depositions are also
      observed in common conditions such as aging and physical inactivity.

      The intervention trial will test in skeletal muscle, liver and heart of sedentary obese
      volunteers, normal weight volunteers and masters athletes, the overall hypotheses that
      exercise improvement of fat oxidation capacity and/or decrease of damaging fat metabolites is
      a primary factor that predicts the improvement in insulin resistance.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Anticipated">October 2019</completion_date>
  <primary_completion_date type="Anticipated">October 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Insulin sensitivity</measure>
    <time_frame>0-4 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Ectopic lipids</measure>
    <time_frame>0-4 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Oxidative capacity</measure>
    <time_frame>0-4 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>0-4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolic flexibility</measure>
    <time_frame>0-4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exercise efficiency</measure>
    <time_frame>0-4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical fitness</measure>
    <time_frame>0-4 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Obesity</condition>
  <condition>Physical Inactivity</condition>
  <condition>Aging</condition>
  <arm_group>
    <arm_group_label>Sedentary obese</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Sedentary normal weight</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Athletes</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Physical activity</intervention_name>
    <description>Supervised exercise intervention</description>
    <arm_group_label>Sedentary obese</arm_group_label>
    <arm_group_label>Sedentary normal weight</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 60-80

          -  Sedentary or highly trained

          -  BMI 18-40

          -  Non-Smoker

          -  Normal glucose tolerance or impaired glucose tolerance

          -  Willingness to comply with the protocol

        Exclusion Criteria:

          -  Contraindication to moderate exercise or clinical conditions precluding from joining
             an exercise program, such as clinically significant cardiovascular disease, peripheral
             vascular disease, uncontrolled hypertension, neurological or orthopedic disease

          -  Recent weight loss or weight gain

          -  Known diabetes

          -  Known drugs to affect glucose homeostasis such as nicotinic acid, glucocorticoids

          -  Severe anemia or lipid disturbances, hepatic or renal disease

          -  Recent history of cancer

          -  Hypothyroidism

          -  Recent hormone replacement therapy

          -  Known allergy to lidocaine or other local anesthetic

          -  Positive stress test

          -  Active alcohol or substance abuse
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francesca Amati, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Lausanne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Francesca Amati, MD, PhD</last_name>
    <phone>+41 21 692 5552</phone>
    <email>francesca.amati@unil.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Bern</name>
      <address>
        <city>Bern</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>UNIL and CHUV</name>
      <address>
        <city>Lausanne</city>
        <zip>1005</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesca Amati, MD, PhD</last_name>
      <phone>+41 21 692 5552</phone>
      <email>francesca.amati@unil.ch</email>
    </contact>
    <investigator>
      <last_name>Francesca Amati, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luc Tappy, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Greggio C, Jha P, Kulkarni SS, Lagarrigue S, Broskey NT, Boutant M, Wang X, Conde Alonso S, Ofori E, Auwerx J, Cantó C, Amati F. Enhanced Respiratory Chain Supercomplex Formation in Response to Exercise in Human Skeletal Muscle. Cell Metab. 2017 Feb 7;25(2):301-311. doi: 10.1016/j.cmet.2016.11.004. Epub 2016 Dec 1.</citation>
    <PMID>27916530</PMID>
  </reference>
  <results_reference>
    <citation>Broskey NT, Boss A, Fares EJ, Greggio C, Gremion G, Schlüter L, Hans D, Kreis R, Boesch C, Amati F. Exercise efficiency relates with mitochondrial content and function in older adults. Physiol Rep. 2015 Jun;3(6). pii: e12418. doi: 10.14814/phy2.12418.</citation>
    <PMID>26059033</PMID>
  </results_reference>
  <results_reference>
    <citation>Broskey NT, Greggio C, Boss A, Boutant M, Dwyer A, Schlueter L, Hans D, Gremion G, Kreis R, Boesch C, Canto C, Amati F. Skeletal muscle mitochondria in the elderly: effects of physical fitness and exercise training. J Clin Endocrinol Metab. 2014 May;99(5):1852-61. doi: 10.1210/jc.2013-3983. Epub 2014 Jan 17.</citation>
    <PMID>24438376</PMID>
  </results_reference>
  <results_reference>
    <citation>Broskey NT, Daraspe J, Humbel BM, Amati F. Skeletal muscle mitochondrial and lipid droplet content assessed with standardized grid sizes for stereology. J Appl Physiol (1985). 2013 Sep 1;115(5):765-70. doi: 10.1152/japplphysiol.00063.2013. Epub 2013 Jun 20.</citation>
    <PMID>23788579</PMID>
  </results_reference>
  <results_reference>
    <citation>Amati F, Broskey NT, Carnero EA. Evidence of systematic and proportional error in a widely used glucose oxidase analyser: impact for clinical research? Clin Endocrinol (Oxf). 2014 May;80(5):768-70. doi: 10.1111/cen.12274. Epub 2013 Jul 19.</citation>
    <PMID>23800101</PMID>
  </results_reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 14, 2010</study_first_submitted>
  <study_first_submitted_qc>October 19, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2010</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Lausanne</investigator_affiliation>
    <investigator_full_name>Francesca Amati</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Aging</keyword>
  <keyword>Insulin resistance</keyword>
  <keyword>Ectopic lipids</keyword>
  <keyword>Obesity</keyword>
  <keyword>Exercise</keyword>
  <keyword>Physical activity</keyword>
  <keyword>Oxidative capacity</keyword>
  <keyword>Diabetes</keyword>
  <keyword>Metabolic syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

